Advisory Board


SAB member Apostle
Charles Cantor, SAB member

Charles Cantor, PhD.

  • Member of National Academy of Sciences
  • Professor Emeritus, Biomedical Engineering, Boston University
  • Founder & Chief Scientific Officer at Sequenom, Inc. (NASDAQ: SQNM, acquired by LabCorp)
  • Chairman, Department of Biomedical Engineering, Boston University
  • Director, Center for Advanced Biotechnology, Boston University
  • Director, the Human Genome Project (HGP)
  • Ph.D., Biophysical Chemistry, University of California, Berkeley
  • A.B., Chemistry, Columbia University
full profile (wiki)
SAB member Apostle
Antonius Schuh, SAB member

Antonius ‘Toni’ Schuh, PhD.

  • Successful serial entrepreneur; over 20 years of executive leadership and founder experience in life sciences industries; CEO of 5 companies; 3 IPOs.
  • Founder, Global Source Ventures
  • Former CEO, Arcturus Bioscience
  • Former CEO, AviaraDx (now bioTheranostics)
  • Former CEO, Sequenom (NASDAQ: SQNM)
  • Former CEO, Sorrento Therapeutics (NASDAQ: SRNE)
  • Former CEO, Trovagene (NASDAQ: TROV)
  • PhD, Pharmaceutical Chemistry, University of Bonn, Germany
full profile (GSV)
SAB member Apostle
John McHutchison, SAB member

John McHutchison, AO, MD.

  • CEO, Assembly Biosciences (NASDAQ: ASMB)
  • Former CSO, Head of R&D, Gilead Sciences (NASDAQ: GILD)
  • Officer of the Order of Australia in recognition of his distinguished service to medical research
  • Professor of Medicine, Duke University Medical Center, Associate Director at Duke Clinical Research Institute and Co-Director of the Duke Clinical and Translational Science Award.
  • Medicine and surgery degrees, University of Melbourne in Australia. Member, the Royal Australasian College of Physicians.
full profile (Assembly Bio)
SAB member Apostle
Dean Felsher, SAB member

Dean Felsher, MD. PhD.

  • Professor. Division of Oncology, Departments of Medicine and Pathology; Director, Translational Research and Applied Medicine; Director of Research, Division of Oncology; Associate Director, Director of Admissions, Medical Scientist Training Program (MSTP); Co-Director, Translational Cancer Nanotechnology Training Program; Stanford University School of Medicine
  • Elected Member, Association of American Physicians
  • M.D. Ph.D., Medicine/Molecular Biology, UCLA
  • B.S., Chemistry, University of Chicago
full profile (Stanford)
SAB member Apostle
Charles (Buck) Strom, SAB member

Charles (Buck) Strom, MD,PhD,FAAP,FACMG,HCLD

  • CEO, Liquid Diagnostics, LLC
  • Co-Director, Head and Neck Cancer Research Center, UCLA School of Dentistry
  • Sole Proprietor: Charles Strom Consultants LLC
  • Vice President, Genetics and Genomics, Quest Diagnostics (NYSE: DGX).
  • MD, University of Chicago, Pritzker School of Medicine
  • PhD, University of Chicago, Department of Biology
  • BS, Yale University, Department of Molecular Biophysics and Biochemistry
full profile (LinkedIn)
SAB member Apostle
David Goldstein SAB member

David B. Goldstein, PhD.

  • John E. Borne Professor of Medical and Surgical Research, Columbia University
  • Founding Director, Institute for Genomic Medicine, Columbia University Medical Center
  • Fellow, AAAS (American Association for the Advancement of Science)
  • Recipient, Royal Society Wolfson Research Merit Award; Triangle Business Journal Health Care Heroes Award; The UNC Institute for Pharmacogenomics and Individualized Therapy (IPIT) Award
  • PhD, Theoretical Population Genetics, Stanford University
  • BS, Biology, UCLA
full profile (Columbia)
SAB member Apostle
hongyu zhao, SAB member

Hongyu Zhao, PhD.

  • Chairman, Biostatistics Department, Yale University
  • Ira V. Hiscock Professor of Biostatistics, Professor of Genetics and Professor of Statistics and Data Science, Yale University
  • Fellow, AAAS (American Association for the Advancement of Science)
  • Fellow, Institute of Mathematical Statistics
  • Fellow, American Statistical Association
  • Ph.D., Statistics, University of California at Berkeley
  • B.S., Probability and Statistics, Peking University
full profile (Yale)
SAB member Apostle
Alexander Hartemink, SAB member

Alexander J. Hartemink, PhD.

  • Professor, Departments of Computer Science and Biology, Duke University
  • Faculty Director, the Office of Undergraduate Scholars and Fellows; Former Director of Graduate Program in Computational Biology and Bioinformatics (CBB), Duke University
  • Ph.D., Electrical Engineering and Computer Science, MIT
  • M.S., Electrical Engineering and Computer Science, MIT; M.Phil., Economics, Oxford University
  • B.S., Mathematics, Physics, and Economics (triple major), Duke University
full profile (Duke)

Management Team


Apostle Inc
David Ge, President Apostle

David Ge, MD. PhD.CEO & President

  • 20+ years of research and industry experience in genomic sciences
  • U.S. Citizen through federal "Outstanding Professors and Researchers"
  • President of BioSciKin Co. & Simcere Diagnostics Co (2016-2017)
  • Director of Bioinformatics, Gilead Sciences (NASDAQ: GILD)(2011-2016)
  • Assistant Professor, Duke University School of Medicine (2008-2011)
  • Ph.D. in Biostatistics & Genetic Epidemiology, CAMS & PUMC (2004)
  • Co-authored 70+ peer-reviewed papers, 5 in Nature and 1 in Science, over 19,000 citations.
Apostle Inc
Wenqi Zeng, SVP of Medicine

Wenqi Zeng, MD. PhD. FACMG.SVP of Medicine

  • 15+ years of research, clinics and industry experience in clinical diagnostics
  • Sr. Director, Molecular Genetics, Quest Diagnostics (NYSE: DGX) (2014-2017)
  • Director of Clinical Genomics at Ambry Genetics (2011-2014)
  • Qualified CAP CLIA lab director in CA, FL and MD; Qualified CAP inspection team leader; New York state COQ in molecular genetics and molecular oncology; Holding diploma of ABMGG
  • PhD, Molecular Genetics
  • Fellow of clinical molecular genetics, human/medical genetics, Harvard Medical School
Apostle Inc
Xin Guo, VP of Bioinformatics

Xin Guo, PhD.VP of Bioinformatics

  • 10+ years of research and industry experience in bioinformatics, artificial intelligence (AI), and HPC
  • VP of Bioinformatics, Simcere Diagnostics, Inc (2016-2017)
  • Group leader, Scientist of Bioinformatics at Gilead Sciences (NASDAQ: GILD). Led the clinical phylogenomic project for Sovaldi®, a world-leading anti-HCV drug (2012-2016)
  • Ph.D. in Computer Science, Duke University (2012)
  • M.S. in Informatics from Max Planck Institute, Germany (2006)
  • Led multiple publications in AI, including in PNAS.
Apostle Inc
Eric D. Masingale, VP of Business Operations

Eric D. MasingaleVP of Business Operations

  • 20+ years of sales experience in medical device industry; Global executive & enterprising business leader
  • Global VP of Sales & Marketing, Stryker Endoscopy (NYSE: SYK) (2006-2012)
  • Global VP of Sales & Marketing, Torax Medical Inc (acquired by J&J) (2012-2014)
  • Director of Sales, West District, Stryker Surgical (NYSE: SYK) (2014-2017)
  • Investor, Director of Sales, West District, Reps Scrubs (2017-2020)
  • B.A., Speech Communications, California State University Hayward
  • Executive Leadership Program, Harvard Business School, 2010, 2013